Current Suspected Overdose Deaths in Delaware for 2021: Get Help Now!
Division of Public Health COVID-19 Testing Data Breach Call Center: 1-833-791-1663 (9 a.m.-9 p.m. Mon-Fri)
New opportunity to participate in an expert-led, interactive training while continuing to practice
DMMA is offering a stipend-sponsored, specialized training to equip participants with the knowledge and skills to treat opioid use disorder through self-paced modules, live discussions, and facilitated webinars, through funding from the Center for Medicare and Medicaid Services (CMS).
Training Objectives for the program include:
Delaware’s program provides stipends for participants - $3,000 for clinical providers and $2000 for practice managers - with assistance through two tracks:
|Clinical Track||Practice Implementation Track|
|For physicians, nurse practitioners, and physician assistants, to build knowledge and skills for effectively assessing and treating OUD in the outpatient setting.||For practice managers and clinical staff who advance operational and administrative aspects of their OBOT program, to provide guidance for developing effective workflows and infrastructure.|
The Fellowship begins February 23, 2021 through September 23, 2021, via an online learning portal.
Training sessions range from 30 minutes to 4 hours per week, depending on the phase of the Fellowship. Training includes:
Phase I: Self-paced modules and interactive sessions with peers and facilitators
Phase II: Expert-led presentations following the American Institutes for Research curriculum with peer to peer exchanges
Phase III: Technical assistance tailored to participating practices for implementing OBOT.
Download this flyer for a summary to share the training information with others.
This project is supported by the Centers for Medicare and Medicaid Services (CMS) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $3,579,864 with 100 percent funded by CMS/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CMS/HHS, or the U.S. Government.